A trial to investigate RedeeFlu in healthy volunteers

Trial Profile

A trial to investigate RedeeFlu in healthy volunteers

Phase of Trial: Phase II

Latest Information Update: 13 Feb 2018

At a glance

  • Drugs H3N2 M2SR influenza vaccine-FluGen (Primary)
  • Indications Influenza A virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2018 New trial record
    • 08 Feb 2018 According to a FluGen media release, this trial is expected to begin in May 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top